Moss, 19 February 2026
Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction has been completed by a primary insider in Gentian:
Frank Frantzen, CTO and primary insider in Gentian, has purchased 3,115 shares in Gentian at NOK 40.00 per share. Mr. Frantzen owns 23,115 shares and 50,000 options after this transaction.
PDMR notification pursuant to the EU Market Abuse Regulation Article 19 is attached.
This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article 19 and Euronext Oslo Rule Book II.
For further information, please contact: Njaal Kind, Group CFO, njaal.kind@gentian.no, +47 91 90 65 25